|
Your search returned 250 studies:
- "Assessment of Risk Factors for Depression Treatment at a Safety Net Clinic" - NCT00984685-18510
Conditions: Depression
Location: Scranton, PA
- 12- Week Open Label Treatment of Refractory Bipolar Depression - NCT00223496-78229
Conditions: Bipolar Disorder
Location: San Antonio, TX
- 12 Week Safety Trial of Flibanserin in Depressed Women Taking a Selective Serotonin Reuptake Inhibitor or Norepinephrine Serotonin Reuptake Inhibitor With Decreased Sexual Desire and Distress - NCT01040208-
Conditions: Sexual Dysfunctions, Psychological - Depression
Location: Seattle, WA
- A Clinic-Based Prevention Program for Families of Depressed Mothers - NCT00149812-21205
Conditions: Depression - Attention Deficit Disorder With Hyperactivity - Conduct Disorder
Location: Baltimore, MD
- A Collaborative Care Program to Improve Depression Treatment in Cardiac Patients - NCT00847132-02114
Conditions: Coronary Artery Disease - Congestive Heart Failure - Arrhythmia - Depression
Location: Boston, MA
- A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care - NCT00939250-75104
Conditions: Type 2 Diabetes - Major Depressive Disorder
Location: Cedar Hill, TX
- A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care - NCT00939250-75237
Conditions: Type 2 Diabetes - Major Depressive Disorder
Location: Dallas, TX
- A Free Treatment Study for Cocaine Dependence Looking at the Effectiveness of Mirtazapine in Treating Cocaine Dependent Individuals Who Also Suffer From Depression - NCT00249444-10032
Conditions: Cocaine Dependence - Depression
Location: New York, NY
- A Pilot Study of TMS Effects on Pain and Depression in Patients With Fibromyalgia - NCT00523302-29425
Conditions: Major Depression - Fibromyalgia
Location: Charleston, SC
- A Prospective Study of Body Image, Social Avoidance and Distress and Psychological Functioning in Burn Patients - NCT01136070-68510
Conditions: Body Image - Depression - Anxiety
Location: Lincoln, NE
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-02190
Conditions: Depression
Location: Weymouth, MA
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-06360
Conditions: Depression
Location: Norwich, CT
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-08046
Conditions: Depression
Location: Willingboro, NJ
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-11235
Conditions: Depression
Location: Brooklyn, NY
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-18049
Conditions: Depression
Location: Emmaus, PA
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-19131
Conditions: Depression
Location: Philadelphia, PA
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-19139
Conditions: Depression
Location: Philadelphia, PA
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-20852
Conditions: Depression
Location: Rockville, MD
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-22903
Conditions: Depression
Location: Charlottesville, VA
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-29201
Conditions: Depression
Location: Columbia, SC
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-32216
Conditions: Depression
Location: Jacksonville, FL
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-32789
Conditions: Depression
Location: Winter Park, FL
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-32806
Conditions: Depression
Location: Orlando, FL
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-44125
Conditions: Depression
Location: Garfield Heights, OH
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-45408
Conditions: Depression
Location: Dayton, OH
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-53226
Conditions: Depression
Location: Milwaukee, WI
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-62711
Conditions: Depression
Location: Springfield, IL
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-63301
Conditions: Depression
Location: St. Charles, MO
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-72223
Conditions: Depression
Location: Little Rock, AR
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-75231
Conditions: Depression
Location: Dallas, TX
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-78229
Conditions: Depression
Location: San Antonio, TX
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-78756
Conditions: Depression
Location: Austin, TX
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-80239
Conditions: Depression
Location: Denver, CO
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-85020
Conditions: Depression
Location: Phoenix, AZ
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-92868
Conditions: Depression
Location: Orange, CA
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-97210
Conditions: Depression
Location: Portland, OR
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880048-97301
Conditions: Depression
Location: Salem, OR
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-02868
Conditions: Depression
Location: Lincoln, RI
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-10029
Conditions: Depression
Location: New York, NY
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-10467
Conditions: Depression
Location: Bronx, NY
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-32751
Conditions: Depression
Location: Maitland, FL
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-32806
Conditions: Depression
Location: Orlando, FL
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-33161
Conditions: Depression
Location: North Miami, FL
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-34208
Conditions: Depression
Location: Bradenton, FL
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-35216
Conditions: Depression
Location: Birmingham, AL
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-43623
Conditions: Depression
Location: Toledo, OH
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-53562
Conditions: Depression
Location: Middleton, WI
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-66212
Conditions: Depression
Location: Overland Park, KS
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-85251
Conditions: Depression
Location: Scottsdale, AZ
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-90210
Conditions: Depression
Location: Beverly Hills, CA
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-91007
Conditions: Depression
Location: Arcadia, CA
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-91786
Conditions: Depression
Location: Upland, CA
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-91950
Conditions: Depression
Location: National City, CA
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder - NCT00880399-98104
Conditions: Depression
Location: Seattle, WA
- A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks - NCT00457106-10003
Conditions: Major Depression With Panic Attacks - Panic Disorder
Location: New York, NY
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-10312
Conditions: Bipolar Depression
Location: Staten Island, NY
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-33155
Conditions: Bipolar Depression
Location: Miami, FL
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-33319
Conditions: Bipolar Depression
Location: Fort Lauderdale, FL
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-38119
Conditions: Bipolar Depression
Location: Memphis, TN
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-44718
Conditions: Bipolar Depression
Location: Canton, OH
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-45219
Conditions: Bipolar Depression
Location: Cincinnati, OH
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-53227
Conditions: Bipolar Depression
Location: West Allis, WI
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-60563
Conditions: Bipolar Depression
Location: Naperville, IL
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-63141
Conditions: Bipolar Depression
Location: Creve Coeur, MO
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-70601
Conditions: Bipolar Depression
Location: Lake Charles, LA
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-73103
Conditions: Bipolar Depression
Location: Oklahoma City, OK
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-75115
Conditions: Bipolar Depression
Location: Desoto, TX
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-78258
Conditions: Bipolar Depression
Location: San Antonio, TX
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-80045
Conditions: Bipolar Depression
Location: Aurora, CO
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-84132
Conditions: Bipolar Depression
Location: Salt Lake City, UT
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-92123
Conditions: Bipolar Depression
Location: San Diego, CA
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression - NCT00844857-98007
Conditions: Bipolar Depression
Location: Bellevue, WA
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-02135
Conditions: Major Depressive Disorder
Location: Boston, MA
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-02478
Conditions: Major Depressive Disorder
Location: Belmont, MA
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-02865
Conditions: Major Depressive Disorder
Location: Lincoln, RI
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-06416
Conditions: Major Depressive Disorder
Location: Cromwell, CT
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-08046
Conditions: Major Depressive Disorder
Location: Willingboro, NJ
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-08755
Conditions: Major Depressive Disorder
Location: Toms River, NJ
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-10305
Conditions: Major Depressive Disorder
Location: Staten Island, NY
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-11235
Conditions: Major Depressive Disorder
Location: Brooklyn, NY
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-14618
Conditions: Major Depressive Disorder
Location: Rochester, NY
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-18104
Conditions: Major Depressive Disorder
Location: Allentown, PA
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-19063
Conditions: Major Depressive Disorder
Location: Media, PA
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-19107
Conditions: Major Depressive Disorder
Location: Philadelphia, PA
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-23230
Conditions: Major Depressive Disorder
Location: Richmond, VA
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-30308
Conditions: Major Depressive Disorder
Location: Atlanta, GA
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-32806
Conditions: Major Depressive Disorder
Location: Orlando, FL
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-33319
Conditions: Major Depressive Disorder
Location: Fort Lauderdale, FL
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-38119
Conditions: Major Depressive Disorder
Location: Memphis, TN
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-41042
Conditions: Major Depressive Disorder
Location: Florence, KY
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-43623
Conditions: Major Depressive Disorder
Location: Toledo, OH
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-44122
Conditions: Major Depressive Disorder
Location: Beachwood, OH
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-47714
Conditions: Major Depressive Disorder
Location: Evansville, IN
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-48083
Conditions: Major Depressive Disorder
Location: Troy, MI
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-53562
Conditions: Major Depressive Disorder
Location: Middleton, WI
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-60194
Conditions: Major Depressive Disorder
Location: Hoffman Estates, IL
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-62711
Conditions: Major Depressive Disorder
Location: Springfield, IL
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-70601
Conditions: Major Depressive Disorder
Location: Lake Charles, LA
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-73109
Conditions: Major Depressive Disorder
Location: Oklahoma City, OK
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-76309
Conditions: Major Depressive Disorder
Location: Wichita Falls, TX
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-91403
Conditions: Major Depressive Disorder
Location: Sherman Oaks, CA
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-97210
Conditions: Major Depressive Disorder
Location: Portland, OR
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-97301
Conditions: Major Depressive Disorder
Location: Salem, OR
- A Study in Depression and Associated Painful Physical Symptoms - NCT01070329-98007
Conditions: Major Depressive Disorder
Location: Bellevue, WA
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-02135
Conditions: Treatment Resistant Depression
Location: Boston, MA
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-02478
Conditions: Treatment Resistant Depression
Location: Belmont, MA
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-03060
Conditions: Treatment Resistant Depression
Location: Nashua, NH
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-05091
Conditions: Treatment Resistant Depression
Location: Woodstock, VT
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-06416
Conditions: Treatment Resistant Depression
Location: Cromwell, CT
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-08002
Conditions: Treatment Resistant Depression
Location: Cherry Hill, NJ
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-10312
Conditions: Treatment Resistant Depression
Location: Staten Island, NY
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-10549
Conditions: Treatment Resistant Depression
Location: Mount Kisco, NY
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-11235
Conditions: Treatment Resistant Depression
Location: Brooklyn, NY
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-11516
Conditions: Treatment Resistant Depression
Location: Cedarhurst, NY
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-18103
Conditions: Treatment Resistant Depression
Location: Allentown, PA
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-19063
Conditions: Treatment Resistant Depression
Location: Media, PA
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-19139
Conditions: Treatment Resistant Depression
Location: Philadelphia, PA
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-20016
Conditions: Treatment Resistant Depression
Location: Washington, DC
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-21061
Conditions: Treatment Resistant Depression
Location: Glen Burnie, MD
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-21285
Conditions: Treatment Resistant Depression
Location: Baltimore, MD
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-30060
Conditions: Treatment Resistant Depression
Location: Marietta, GA
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-30308
Conditions: Treatment Resistant Depression
Location: Atlanta, GA
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-33912
Conditions: Treatment Resistant Depression
Location: Fort Myers, FL
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-41042
Conditions: Treatment Resistant Depression
Location: Florence, KY
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-43623
Conditions: Treatment Resistant Depression
Location: Toledo, OH
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-44122
Conditions: Treatment Resistant Depression
Location: Beachwood, OH
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-45227
Conditions: Treatment Resistant Depression
Location: Cincinnati, OH
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-47905
Conditions: Treatment Resistant Depression
Location: Lafayette, IN
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-53223
Conditions: Treatment Resistant Depression
Location: Brown Deer, WI
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-53227
Conditions: Treatment Resistant Depression
Location: West Allis, WI
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-53562
Conditions: Treatment Resistant Depression
Location: Middleton, WI
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-60523
Conditions: Treatment Resistant Depression
Location: Oak Brook, IL
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-60640
Conditions: Treatment Resistant Depression
Location: Chicago, IL
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-63044
Conditions: Treatment Resistant Depression
Location: Bridgeton, MO
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-63141
Conditions: Treatment Resistant Depression
Location: St Louis, MO
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-63301
Conditions: Treatment Resistant Depression
Location: St. Charles, MO
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-77566
Conditions: Treatment Resistant Depression
Location: Lake Jackson, TX
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-78756
Conditions: Treatment Resistant Depression
Location: Austin, TX
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-91107
Conditions: Treatment Resistant Depression
Location: Pasadena, CA
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-91403
Conditions: Treatment Resistant Depression
Location: Sherman Oaks, CA
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-92595
Conditions: Treatment Resistant Depression
Location: Wildomar, CA
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-92660
Conditions: Treatment Resistant Depression
Location: Newport Beach, CA
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-98004
Conditions: Treatment Resistant Depression
Location: Bellevue, WA
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-98104
Conditions: Treatment Resistant Depression
Location: Seattle, WA
- A Study in Relapse Prevention of Treatment-resistant Depression - NCT00958568-99204
Conditions: Treatment Resistant Depression
Location: Spokane, WA
- A Study of Infliximab for Treatment Resistant Major Depression - NCT00463580-30322
Conditions: Treatment Resistant Depression - Current Diagnosis: Major Depressive Disorder or Bipolar Disorder I or II: Current Episode, Depressed
Location: Atlanta, GA
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-02139
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Cambridge, MA
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-06457
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Middletown, CT
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-08046
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Willingboro, NJ
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-08755
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Toms River, NJ
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-10523
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Elmsford, NY
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-11004
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Glen Oaks, NY
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-11516
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Cedarhurst, NY
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-18104
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Allentown, PA
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-19131
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Philadelphia, PA
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-19139
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Philadelphia, PA
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-23230
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Richmond, VA
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-27157
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Winston-Salem, NC
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-27603
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Raleigh, NC
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-29405
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Charleston, SC
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-30308
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Atlanta, GA
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-32606
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Gainesville, FL
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-33021
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Hollywood, FL
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-33180
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Aventura, FL
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-34741
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Kissimmee, FL
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-35294
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Birmingham, AL
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-39232
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Flowood, MS
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-44122
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Beachwood, OH
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-45267
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Cincinnati, OH
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-46202
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Indianapolis, IN
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-55454
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Minneapolis, MN
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-60076
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Skokie, IL
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-60169
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Hoffman Estates, IL
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-63118
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: St. Louis, MO
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-75115
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: DeSoto, TX
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-75243
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Dallas, TX
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-77008
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Houston, TX
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-77074
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Houston, TX
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-78229
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: San Antonio, TX
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-78754
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Austin, TX
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-80204
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Denver, CO
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-85724
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Tucson, AZ
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-90048
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Los Angeles, CA
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-91204
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Glendale, CA
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-91950
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: National City, CA
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-92056
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Oceanside, CA
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-92123
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: San Diego, CA
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-92126
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: San Diego, CA
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-92627
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Costa Mesa, CA
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-92705
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Santa Ana, CA
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features - NCT00637494-98033
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Kirkland, WA
- A Study of RO4917523 in Patients With Treatment Resistant Depression - NCT00809562-06511
Conditions: Depression
Location: New Haven, CT
- A Study of RO4917523 in Patients With Treatment Resistant Depression - NCT00809562-10029
Conditions: Depression
Location: New York, NY
- A Study of RO4917523 in Patients With Treatment Resistant Depression - NCT00809562-10032
Conditions: Depression
Location: New York, NY
- A Study of RO4917523 in Patients With Treatment Resistant Depression - NCT00809562-10065
Conditions: Depression
Location: New York, NY
- A Study of RO4917523 in Patients With Treatment Resistant Depression - NCT00809562-39232
Conditions: Depression
Location: Flowood, MS
- A Study of RO4917523 in Patients With Treatment Resistant Depression - NCT00809562-71104
Conditions: Depression
Location: Shreveport, LA
- A Study of RO4917523 in Patients With Treatment Resistant Depression - NCT00809562-92056
Conditions: Depression
Location: Oceanside, CA
- A Study of RO4917523 in Patients With Treatment Resistant Depression - NCT00809562-92103
Conditions: Depression
Location: San Diego, CA
- A Study of RO4917523 in Patients With Treatment Resistant Depression - NCT00809562-PITTS
Conditions: Depression
Location: 15213, PA
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-02721
Conditions: Major Depressive Disorder
Location: Fall River, MA
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-02865
Conditions: Major Depressive Disorder
Location: Lincoln, RI
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-06360
Conditions: Major Depressive Disorder
Location: Norwich, CT
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-10467
Conditions: Major Depressive Disorder
Location: Bronx, NY
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-11235
Conditions: Major Depressive Disorder
Location: Brooklyn, NY
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-11366
Conditions: Major Depressive Disorder
Location: Fresh Meadows, NY
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-14215
Conditions: Major Depressive Disorder
Location: Buffalo, NY
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-18103
Conditions: Major Depressive Disorder
Location: Allentown, PA
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-19063
Conditions: Major Depressive Disorder
Location: Media, PA
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-30328
Conditions: Major Depressive Disorder
Location: Atlanta, GA
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-32216
Conditions: Major Depressive Disorder
Location: Jacksonville, FL
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-32751
Conditions: Major Depressive Disorder
Location: Maitland, FL
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-33716
Conditions: Major Depressive Disorder
Location: St. Petersburg, FL
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-43623
Conditions: Major Depressive Disorder
Location: Toledo, OH
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-45417
Conditions: Major Depressive Disorder
Location: Dayton, OH
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-47802
Conditions: Major Depressive Disorder
Location: Terre Haute, IN
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-53223
Conditions: Major Depressive Disorder
Location: Brown Deer, WI
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-60068
Conditions: Major Depressive Disorder
Location: Park Ridge, IL
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-60076
Conditions: Major Depressive Disorder
Location: Skokie, IL
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-63301
Conditions: Major Depressive Disorder
Location: St. Charles, MO
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-67207
Conditions: Major Depressive Disorder
Location: Wichita, KS
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-70114
Conditions: Major Depressive Disorder
Location: New Orleans, LA
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-70601
Conditions: Major Depressive Disorder
Location: Lake Charles, LA
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-71115
Conditions: Major Depressive Disorder
Location: Shreveport, LA
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-72223
Conditions: Major Depressive Disorder
Location: Little Rock, AR
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-73103
Conditions: Major Depressive Disorder
Location: Oklahoma City, OK
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-77007
Conditions: Major Depressive Disorder
Location: Houston, TX
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-78756
Conditions: Major Depressive Disorder
Location: Austin, TX
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-80239
Conditions: Major Depressive Disorder
Location: Denver, CO
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-84107
Conditions: Major Depressive Disorder
Location: Salt Lake City, UT
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-90210
Conditions: Major Depressive Disorder
Location: Beverly Hills, CA
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-91950
Conditions: Major Depressive Disorder
Location: National City, CA
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-92123
Conditions: Major Depressive Disorder
Location: San Diego, CA
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-92845
Conditions: Major Depressive Disorder
Location: Garden Grove, CA
- A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression - NCT01098240-97210
Conditions: Major Depressive Disorder
Location: Portland, OR
- A Study to Asses the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder - NCT01153347-
Conditions: Major Depressive Disorder - Depression
Location: Brown Deer, WI
- A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD) - NCT01157078-
Conditions: Major Depressive Disorder - Depression
Location: Seattle, WA
- A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression - NCT00812058-02114
Conditions: Bipolar I Depression
Location: Boston, MA
- A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression - NCT00812058-02856
Conditions: Bipolar I Depression
Location: Lincoln, RI
- A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression - NCT00812058-06519
Conditions: Bipolar I Depression
Location: New Haven, CT
- A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression - NCT00812058-10305
Conditions: Bipolar I Depression
Location: Staten Island, NY
- A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression - NCT00812058-15213
Conditions: Bipolar I Depression
Location: Pittsburg, PA
- A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression - NCT00812058-21205
Conditions: Bipolar I Depression
Location: Baltimore, MD
- A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression - NCT00812058-22903
Conditions: Bipolar I Depression
Location: Charlottesville, VA
- A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression - NCT00812058-27599
Conditions: Bipolar I Depression
Location: Chapel Hill, NC
- A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression - NCT00812058-27609
Conditions: Bipolar I Depression
Location: Raleigh, NC
- A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression - NCT00812058-27710
Conditions: Bipolar I Depression
Location: Durham, NC
- A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression - NCT00812058-29401
Conditions: Bipolar I Depression
Location: Charleston, SC
- A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression - NCT00812058-30080
Conditions: Bipolar I Depression
Location: Smyrna, GA
- A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression - NCT00812058-30308
Conditions: Bipolar I Depression
Location: Atlanta, GA
|
|